Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, T-Cell × Clinical Protocols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Lymphoma, T-Cell 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

liposomal doxorubicin 1 Salvia hispanica seed extract 1 Prednisone 1 Methotrexate 1 Clinical Protocols 1 Cholecalciferol 1 Azacitidine 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05772728 2023-03-16

Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡